Evidence map›Paper›PMID 41276621›Full record

ArticleScientific reports2025

Upgrading of NiFe

Basir Maleki, Hossein Esmaeili

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Basir MalekiDepartment of Chemical Engineering, Esfarayen University of Technology, Esfarayen, North Khorasan, Iran. b.maleki@esfarayen.ac.ir.
Hossein EsmaeiliDepartment of Chemical Engineering, Bushehr Branch, Islamic Azad University, Bushehr, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, NiFe2O4@g-C3N4 nanocatalyst was synthesized using ultrasonication and pyrolysis techniques and subsequently applied as a highly efficient and reusable catalyst for biodiesel production from waste cooking oil (WCO). Comprehensive structural analyses such as X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), Brunauer–Emmett–Teller (BET), energy-dispersive X-ray spectroscopy (EDX), field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), Raman spectroscopy, carbon dioxide temperature-programmed desorption (CO2-TPD), and vibrating sample magnetometry (VSM) confirmed that the NiFe2O4@g-C3N4 nanocatalyst possesses a high specific surface area coupled with notable magnetic features, facilitating its effectiveness in catalysis and ease of separation post-reaction. Under optimized conditions of 2.85 wt% catalyst dosage, 11.72:1 methanol-to-oil molar ratio, 61.17 °C reaction temperature, and 24 kHz ultrasound frequency (250 W), the NiFe2O4@g-C3N4 nanocatalyst achieved a maximum biodiesel yield of 98.83% within 31.02 min. Additionally, the catalyst demonstrated remarkable stability and reusability, maintaining a biodiesel yield of over 90% even after seven consecutive reuse cycles. The reaction kinetics revealed that the process follows a pseudo-first-order model. Kinetic and thermodynamic evaluations of the transesterification process revealed that the reaction is endothermic, with an enthalpy change (ΔH°) of 98.5 kJ/mol. The activation energy of 101.2 kJ/mol indicated that the NiFe2O4@g-C3N4 nanocatalyst possesses sufficient energy to drive the transesterification reaction efficiently. These results highlight the incorporation of g-C₃N₄ nanoparticles to reinforce NiFe₂O₄, which enhances its surface area, magnetic recoverability, and structural stability attributes that significantly improve catalytic activity and reusability in biodiesel production.

Indexed as

BiodieselKineticNanocatalystNiFe2O4@g-C3N4Response surface methodologyWaste cooking oil

Identifiers

PMID41276621
PMCPMC12748765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.